New pill aims to stop muscle wasting in Weight-Loss patients
Disease control
Recruiting now
This study is testing a new oral drug, ACM-001.1, to see if it can help people with obesity keep their muscle while they lose weight using the medication semaglutide. It will involve about 120 participants and has two parts: one where the new drug is taken alongside semaglutide, …
Phase: PHASE2 • Sponsor: Actimed Therapeutics Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC